The impact of sexually transmitted diseases on quality of life: application of three validated measures

The attitude and practice towards patients with sexually transmitted diseases (STDs) are of ongoing interest, particularly since these infections have had an increasing worldwide distribution over the years. Methods. Big five questionnaire (BFQ), Rosenberg self-esteem (RSE) and Experience of shame scale (ESS) were administered to women diagnosed with human papilloma virus (HPV) (n=30), chlamydia trachomatis (CT) (n=30) and trichomonas vaginalis (TV) (n=29). Analysis of variance (ANOVA) and Pearson's correlation were run for statistical evaluation. Results. Data suggested that experiences of shame and self- esteem were negatively and significantly associated. Length of pathology was found to be the most relevant factor interfering with Quality of life (QoL). It weakens the personality and reduces the capability to face daily problems. In addition, the fear of serious complications can create a psychological state of depression. Subsequently, regarding its possible consequences (e.g., carcinoma), HPV potentially has a higher impact on patients' psychological wellness in comparison with TV and CT. Conclusions. Women with STDs experience frustration, anxiety, anger, fear of rejection, isolation, guilt, embarrassment, shame and feelings of physical filth or contamination. These negative psychological effects are potentially more important than the medical effects of the disease. Communication between doctor and patient needs to be improved to increase early intervention.